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Abstract: It is known that long lasting changes in cell volume are incompatible with cellular functions. In the present 
review, I discussed the role of cell volume on gene expression and protein synthesis as well as the importance of the renin 
angiotensin system on the regulation of cell volume in the failing heart. Moreover, the relationship between mechanical 
stretch, cell volume and the renin angiotensin system as well some translational studies are also described and their 
relevance to the prevention or reduction of cardiac damage during myocardial ischemia is emphasized. 
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INTRODUCTION 
  Animal cells are surrounded by a membrane highly 
permeable to water [1] and osmosis is an important cause of 
water transport across the surface cell membrane generating 
changes in cell volume. It is well known that long lasting 
variations in cell volume are incompatible with cell functions 
and consequently, the preservation of normal cell volume is 
of fundamental importance to cell biology. This difficult task 
is accomplished through complex mechanisms including two 
major ionic transport systems: a) the Na-K—2Cl cotransport 
[2] and b) the Na/H exchanger [3] which alkalizes the cell 
with consequent activation of Cl/HCO3 exchanger. 
Variations in cell volume cause important changes in cellular 
functions like the activation stretch-sensitive ion channels, 
change in metabolism, gene expression and protein synthesis 
[4, 5]. Hypotonic stress induced by ischemia, for instance, 
leads to accumulation of metabolites intracellularly with 
consequent cell swelling due to water entering the cell. 
Moreover, long-lasting myocardial ischemia causes profound 
changes in cellular physiology including alteration in genetic 
expression as evidenced by the finding that hypertonic 
solution or high ionic strength stimulates the expression
 of 
aldose reductase and the Na
+-coupled transport systems for 
several
 amino acids which increase intracellular osmolarity 
counteracting the enhanced extracellular osmotic pressure 
[6]. Cell shrinkage increases the expression of heat shock 
proteins and
 of other proteins such as P-glycoprotein, ClC-
K1, and Na
+-K
+-ATPase 1-subunit, cyclooxygenase-2, the 
GTPase-activating protein
  for Rac 1-chimerin, the 
immediate early gene transcription factors
 Egr1-1 and c-Fos, 
vasopressin, phosphoenolpyruvate carboxykinase,
  tyrosine 
aminotransferase, tyrosine hydroxylase, dopamine -
hydroxylase,
 matrix metalloproteinase 9, and several matrix 
proteins [7]. Cell swelling, on the other hand, increases the 
expression of proteins like -actin, tubulin, cyclooxygenase-
2, extracellular
 signal-regulated kinases ERK-1 and ERK-2, 
JNK, the transcription
  factors c-Jun and c-Fos, ornithine 
decarboxylase, and tissue plasminogen
  activator [7]. 
However, our knowledge of the mechanisms involved in the 
changes in gene expression is meager [8]. 
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RENIN ANGIOTENSIN SYSTEM REGULATES THE 
HEART VOLUME. INTRACRINE VS. EXTRACELLU-
LAR RENIN AND ANGIOTENSIN II 
  Evidence is available that the plasma renin angiotensin 
system is involved in the regulation of blood volume and 
arterial blood pressure and that there is a local renin 
angiotensin system in the heart which promotes cardiac 
remodeling, changes in cell communication and inward 
calcium current in the normal and in the failing heart [9 -11]. 
In addition, angiotensin II and renin dialyzed into the cell, 
causes cell uncoupling - an effect suppressed by ACE 
inhibitors and AT1 blockers [9,10] supporting the view that 
there is an intracellular renin angiotensin system [9-12]. 
Recent observations [13] indicated that the renin angiotensin 
aldosterone system is involved in the regulation of cell 
volume in the normal and particularly in the failing heart. 
Indeed, extracellular renin or Ang II increases the cell 
volume in normal and failing heart through the inhibition of 
the sodium pump and the activation of the Na-K-2Cl 
cotransporter [13] while intracellular renin and Ang II 
reduces the cell volume by enhancing the electrogenic 
sodium- potassium pump [13]. This is a finding of seminal 
importance to heart cell biology because alterations of cell 
volume induce the release of ATP, hormones like insulin and 
renin, neurotransmitters [7] and activates plasma membrane 
receptors and integrins which also participate in the 
regulation of cell volume [1]. On the other hand, cell volume 
regulation following cell swelling involves the efflux of ions 
through activation of K+ channels and or anion channels and 
parallel activation of K+/H+ exchange and Cl/HCO3 
exchange while cell shrinkage causes accumulation of ions 
through different mechanisms including activation of the Na-
K-2Cl cotransporter and Na+/H+ exchanger [7]. It is then 
conceivable that intracellular renin and Ang II play an 
important role re-establishing the cell volume increased 
during normal or pathological conditions. Indeed, it is 
recognized that alteration of cell volume regulation 
contributes to several diseases such as diabetic ketoacidosis, 
liver insufficiency, sickle cell anemia and infection [7] and 
that cell swelling-activated Cl current (ICl swell), which is 
broadly distributed throughout the heart, shortens the action 
potential, depolarizes the cell membrane, and is a potential 
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transcript that does not encode a secretory signal [15] and is 
over-expressed during myocardial infarction, raises the 
possibility that intracellular renin has an important role in the 
regulation of heart cell volume which is relevant during 
myocardial ischemia [27]. 
MECHANICAL STRETCH, CELL VOLUME AND 
RENIN ANGIOTENSIN SYSTEM 
  During heart failure, ventricular hypertrophy or dilatation 
as that seen in dilated cardiomyopathy, elicits mechanical 
stress with concurrent changes of extracellular matrix and 
cytoskeleton [16,17]. On the other hand, ICl,swell  which is 
implicated in the regulation of cell volume in all types of 
cells [18], is activated by cell swelling during 
ischemia/reperfusion [14,19-21]. Myocardial ischemia which 
generates mechanical forces and deformation of cell 
membrane [14,] with consequent increase of tension of 
surface cell membrane, activates several ionic channels 
enhancing their open probability without altering single 
channel conductance [18]. Mechanical stress or cell swelling 
also stimulates protein kinase C [22, 23] and increases 
tyrosine phosphorylation
  of several proteins [7], a finding 
particularly relevant because it is known that Ang II changes 
the inward calcium current in the heart through the activation 
of PKC and tyrosine kinases [24]. Membrane stretch and 
ionic channel activation might involve: a) the release of fatty 
acids from the membrane and activation of stretch-sensitive 
channels; b) stretch activation of some component of the 
cytoskeleton such as spectrin [see 7]. It is known that 
stretching depolarizes the heart cell membrane during 
diastole, changes the action potential and produces 
arrhythmias [25] and that part of these effects are mediated 
by stretch-activated ion channels [25]. Interestingly, 
mechanical stress activates angiotensin II AT1 receptors 
independently of angiotensin II [26] suggesting that the AT1 
receptor is a mechanical sensor by itself or it is associated 
with stretch sensors such as integrins [26]. Because chronic 
deformation of surface cell membrane like that seen in heart 
failure, essential hypertension and myocardial ischemia 
causes mechanical stress, alteration of genetic expression 
and changes in heart cell excitability are likely events which 
might be in part associated with AT1 receptor activation 
[28]. 
INTRACELLULAR  VS. EXTRACELLULAR RENIN, 
ANGIOTENSIN II AND CELL VOLUME 
  Of particular interest was the recent finding that 
intracellular dialysis of Ang II in myocytes isolated from the 
failing heart, reverses the increase of cell volume elicited by 
hypotonic solution [13] raising the possibility that the 
activation of the intracellular renin angiotensin system [11] 
be beneficial during myocardial ischemia by reducing cell 
volume. Consequently, there is a decrease of the activation 
of ICl,swell and prevention of action potential shortening, an 
important cause of cardiac arrhythmias. Interestingly, 
extracellular renin and Ang II have opposite effects on cell 
volume inhibiting the sodium pump and activating the Na-K-
2Cl cotransporter with consequent increase of cell volume 
[13]. These findings support the view that the renin 
angiotensin system is involved in the regulation of cell 
volume and that the activation of plasma renin angiotensin 
system is harmful during ischemia/reperfusion when the cell 
volume is already increased (Fig. 1). Indeed, it is known that 
angiotensin II contributes to heart damage during ischemia/ 
reperfusion and that Ang II AT1 receptor blockers as well as 
ACE inhibitors have protective effects in experimental 
animal models of myocardial ischemia as well as in humans 
[28]. Since evidence is available that the Na-K-2 Cl 
cotrasporter is constantly activated during heart failure [14], 
the question remains if there is a relation between the 
activation of the renin angiotensin system and the activation 
of the cotransporter. If this is the case, the beneficial effect 
of ACE inhibitors and angiotensin II AT1 receptor blockers 
during myocardial ischemia is related, at least in part, to the 
suppression of the effect of angiotensin II on cell volume. 
 
Fig. (1). Diagram illustrating the influence of myocardial ischemia 
on heart cell volume, the potentiating effect of plasma RAS 
activation and the influence of the intracellular renin and 
angiotensin II as well as extracellular angiotensin (1-7) on cell 
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ACE2, ANGIOTENSIN (1-7) AND CELL VOLUME ? 
  Angiotensin II, however, is hydrolyzed to angiotensin (1-
7) by ACE2 [29] with consequent the generation of 
angiotensin (1-7), which counteracts some harmful effects of 
Ang II [30] including the block of impulse propagation seen 
during ischemia/reperfusion. The beneficial effect of 
angiotensin (1-7) on impulse propagation is related to the 
activation of the sodium pump and hyperpolarization of cell 
membrane [31]. Since ACE2 is over-expressed during heart 
failure [32, 33], one wonders if the enhanced expression of 
ACE2 is involved on the regulation of heart cell volume. 
This hypothesis seems to be supported by recent findings 
that angiotensin (1-7) increments the sodium pump and 
reduces the cell volume by 15% within 25 minutes in the 
failing heart [De Mello, unpublished]. It is then conceivable 
that the improvement of cardiac function and decreased 
incidence of cardiac arrhythmias during ischemia/reperfusion 
elicited by Ang (1-7), be related, at least in part, to the 
decrease of heart cell volume (Fig. 1). According to these 
findings, the balance between ACE and ACE2 expression 
seems to be a determinant factor on the regulation of cell 
function and cell volume and that the beneficial effect of 
ACE inhibitors or AT1 receptor blockers during myocardial 
ischemia and heart failure be related to the prevention of cell 
swelling induced by extracellular renin and angiotensin II. 
On the other hand, intracellular renin and angiotensin II 
might be beneficial by reducing the cell swelling. 
CARDIOPROTECTION AGAINST ISCHEMIA/RE-
PERFUSION INJURY. TRANSLATIONAL STUDIES 
  Translational studies are of fundamental importance for 
the prevention or treatment of the harmful effects of 
myocardial ischemia including the changes in cellular 
volume. Currently, two major strategies have being tried: a) 
continuous promotion of cardioprotective factors; b) 
treatment of cardiac damage. Adenosine and KATP channel 
opener nicorandil ameliorate reperfusion injury in the 
clinical setting [34]. Concerning gene therapy, a 
cardioprotective effect has been successfully obtained 
through genetic modulation of PKC-epsilon [35] and of NO 
synthase [36].As emphasized by different authors, the major 
problem is to identify the target clinical population for these 
therapies before symptoms and signs are develop in order to 
prevent heart damage. Tumor necrosis factor (TNF), for 
instance, is enhanced in myocardial tissue after 
ischemia/reperfusion and it is known to induce 
preinflammatory signaling. Indeed, in humans, there is a 
direct correlation between circulating levels of TNF and 
functional capacity and survival [37] what suggests that, at 
least in male, blockade of 55-kDA TNF receptor be 
beneficial during ischemia/reperfusion. Future translational 
studies will certainly provide the appropriate target clinical 
population for each of these alternatives and will offer new 
avenues for the prevention of cardiac damage during 
ischemia reperfusion and the consequent change in heart cell 
volume. 
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